Home / Inspections / 1106753

FDA Inspection 1106753 — Rhode Island Blood Center, A Division of New York Blood Center, Inc.

Rhode Island Blood Center, A Division of New York Blood Center, Inc. — FEI 1270007

The FDA completed an inspection of Rhode Island Blood Center, A Division of New York Blood Center, Inc. on July 26, 2019 in Providence, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Providence, RI (United States)

Facility

Other inspections at this facility

  • 1277157 (NAI Fri Aug 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1201246 (NAI Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 995774 (NAI Mon Nov 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 891892 (VAI Wed Aug 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 788124 (VAI Thu Jun 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources